ImmuCell Corporation (ICCC) — Cash Flow Quality Index
ImmuCell Corporation (ICCC) has a Cash Flow Quality Index of 3.19x as of June 2025. Operating cash flow of $1.60 Million exceeds net income of $501.88K, indicating high earnings quality where cash backs reported profits. Explore ICCC strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ImmuCell Corporation Cash Flow Quality Index (1997–2016)
Historical Cash Flow Quality Index for ImmuCell Corporation across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ImmuCell Corporation (ICCC) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ImmuCell Corporation (1997–2016)
Year-by-year earnings quality comparison for ImmuCell Corporation. For live market cap and the full company financial profile, see ImmuCell Corporation (ICCC) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | -0.64x | $-323.90K | $508.45K | ▼ -126.6% |
| 2015 | 2.39x | $2.90 Million | $1.21 Million | ▼ -74.5% |
| 2013 | 9.36x | $1.10 Million | $117.39K | ▲ +143.2% |
| 2012 | 3.85x | $344.39K | $89.51K | ▲ +628.8% |
| 2007 | 0.53x | $349.56K | $662.14K | ▼ -94.4% |
| 2006 | 9.46x | $1.36 Million | $143.52K | ▲ +775.7% |
| 2005 | 1.08x | $764.78K | $707.78K | ▼ -88.6% |
| 2004 | 9.46x | $1.36 Million | $143.52K | ▲ +177.2% |
| 2003 | 3.41x | $1.40 Million | $411.22K | ▲ +59.4% |
| 2002 | 2.14x | $1.90 Million | $886.24K | ▼ -0.7% |
| 2001 | 2.16x | $906.00K | $420.00K | ▲ +5781.0% |
| 2000 | 0.04x | $81.50K | $2.22 Million | ▼ -97.0% |
| 1999 | 1.23x | $679.70K | $550.84K | ▲ +270.2% |
| 1997 | 0.33x | $100.00K | $300.00K | — |